Clinigen shares took a bit of a battering today (down 10pc) following a mini profit warning from the company that 2021's profits will be at the "lower end" of guidance.
This is, according to the company, because of the impact of COVID-19 and an expected launch of a generic Foscavir in the Eruopean Union...
It would appear former colleagues at The Sunday Times got wind of the Clinigen takeover tale, too.
Yesterday, the business section of the The Sunday Times ran a rather similar tale to Betaville's UNCOOKED Alert from a ten days ago. Below is the link:..
Advent International is the mystery buyer stalking Clinigen but it's not clear whether it is still in "live" takeover talks with the Aim-listed medical supplies company.
Several people following the situation said Advent - which has carried out several investments in the healthcare and pharmaceutical industries - has been working Goldman Sachs and HSBC on a multi-million debt package for a possible takeover of Clinigen...
Clinigen, an Aim-listed medical supplies company, has come under the spotlight amid takeover talk.
People following the situation said a potential acquirer is eyeing the company, which supplies drugs for clinical trials and also distributes unlicensed pharmaceuticals to pharmacists.
One person following the situation suggested purchaser could be a private equity firm...